Seasonality Snapshot

AbbVie (ABBV)

Biopharma · US · US Healthcare & Biotech
✓ VERIFIED · 14YR REAL DATA
JanFebMarAprMayJunJulAugSepOctNovDec
NEUTRAL SEASONALITY — August
Strongest Month
November
+6.38% avg · 77% win rate
Weakest Month
January
-1.69% avg · 31% win rate
MonthAvg ReturnWin Rate
January -1.69% 31%
February +3.91% 86%
March +0.11% 71%
April +1.67% 57%
May +0.42% 64%
June +1.93% 50%
July +2.10% 64%
August NOW +0.66% 50%
September +1.49% 54%
October +1.74% 62%
November +6.38% 77%
December +2.57% 69%
These figures are computed from 14 years of actual monthly closing prices. Past seasonal patterns are not a guarantee of future performance. See our methodology for how this is calculated, or visit the Academy to learn how to read seasonal data responsibly.

AbbVie seasonality — common questions

What is AbbVie's best month historically?
Historically, November has been AbbVie's strongest month, averaging +6.38% with a 77% win rate over 14 years of data. January has been the weakest at -1.69%.
Is AbbVie seasonal?
AbbVie shows a measurable seasonal pattern: its best and worst months differ by 8.07 percentage points on average. These figures come from 14 years of real monthly closing prices. Seasonality is a historical tendency, not a prediction.
How does AbbVie historically perform in August?
AbbVie is currently in August, which has historically averaged +0.66% with a 50% win rate. That is a historically neutral window.

Get the full analysis

Backtest this seasonal pattern, compare it against other assets, set alerts, and explore detrended & presidential-cycle views.

Open the Analyzer →
TimingAX is an independently operated service, not a registered investment adviser. This page is for informational purposes only and is not financial advice.